The whey proteins are rich sources of leucine and affect mTOR-mediated skeletal muscle protein synthesis. The present authors wished to investigate the dose-response effect of chronic supplementation of the whey proteins (WP) with leucine on the anabolic pathway proteins mTOR and p70S6K in the diaphragm of sedentary and exercised Wistar rats. Ninety-six weanling male Wistar rats were divided into eight groups and fed for 30 day diets containing either casein or WP, with increasing levels (0, 3, 4.5 and 6% of the diet) of leucine. A parallel set of eight groups was exercised for comparison. Serum uric acid, creatinine, glucose, AST, ALT, CK, LDH and cholesterol, were determined by standard methods, and mTOR and p70S6K, using the Western blot analysis. Leucine supplementation increased both, mTOR and p70S6K in the diaphragm in a dose-dependent way, independent of the type of dietary protein. These changes produced no significant increase in either diaphragm or protein mass.
amino acids (BCAAs) (Korhonen, 2009; Marshall, 2004) , which could play a further role in its physiological effects (Lollo, Amaya-Farfan, & Carvalho-Silva, 2011) .
It is well known that high quality proteins can stimulate protein synthesis at higher rates than lower quality proteins (Yoshizawa, Kido, & Nagasawa, 1999) . The whey proteins (WP) possess high nutritive quality and high speed of digestion and absorption, thus providing a fast and profuse supply of amino acids and small peptides (Korhonen, 2009) . For this reason, the whey proteins have been recognized as promoting a positive metabolic balance, being classified by some researchers as rapidly metabolized proteins (Boirie et al., 1997; Fruhbeck, 1998) , thus making them attractive for situations of metabolic stress, including that caused by physical exercise (Nery-Diez et al., 2010) , muscle mass loss (Agin et al., 2001) , neurological disorders (Carvalho- Silva et al., 2010) , and immune deficiencies, amongst others (Marshall, 2004) . It is pertinent to note that the BCAA (branched-chain amino acids) concentrations in the whey proteins, including leucine, are high. Altogether, BCAAs account for 21.2% of the amino acids that make up the whey proteins, or exactly 50% of the total of indispensable amino acids therein, a feature that is shared with few other proteins besides the skeletal muscle proteins (Ha & Zemel, 2003) , the main differences of skeletal muscle and diaphragm are: a) the diaphragm works nonstop throughout life; b) has a high concentration of muscle fibers type I and c) using predominantly aerobic metabolism, thus the simple extrapolation from other works is not enough (Chervin & Guilleminault, 1997; Oh-ishi et al., 1997; Sassoon & Caiozzo, 2009 ).
Considering, a) the unique characteristics of the diaphragm and the interest in anabolic stimulation of this muscle (Oh-ishi et al., 1997) ; b) the effect of exercise in the increase in mass and functionality of the exercised muscle (Tipton & Ferrando, 2008; Van Lunteren & Moyer, 2003; Vrabas et al., 1999) ; c) the anabolic power of leucine and whey protein (Anthony et al., 2001; Tipton & Ferrando, 2008) ; and d) the lack of data on the possible effects of this combination, leucine +whey protein +exercise in the diaphragm, the hypothesis of this study was: the combination of whey protein, leucine and exercise could activate the mTOR anabolic pathway of the diaphragm and hypertrophy of this muscle, although the milk proteins having high concentrations of leucine present in casein or whey proteins are not enough to reach levels that activate the mTOR pathway described by Anthony et al. (2001) . The objective of this work was therefore to determine the effects of four levels (0, 3, 4.5 and 6%) of long-term supplementation with leucine-rich whey proteins on the concentrations of mTOR and p70S6K, in both, the phosphorylated and non-phosphorylated forms, on the diaphragms of trained and sedentary Wistar rats.
Material and methods

Design
Male Wistar (21-day old, specific-pathogen free; n = 96) rats, bred in the Multidisciplinary Center for Biological Research, University of Campinas, SP, Brazil, were housed (~22°C, 55% RH, inverted 12-hour light cycle) in 96 individual growth cages (one per animal), with free access to commercial chow (Labina, Purina, Brazil) and water at all times, until they weighed 133.82± 5.6 g. The animals were randomly assigned to any of sixteen groups according to the protein source in the diet, leucine supplementation and whether they were exercised or sedentary (Fig. 1 ). The research methodology was approved by the Ethics Committee on Animal Experimentation (CEEA-UNICAMP, protocol 1835-1).
Training protocol
The rats were selected beforehand on the treadmill, considering as not fit those that remained without departing from the baseline for 30 s. The animals began training on the day they started to consume the experimental diets, and continued for 4 weeks following the progressive protocol of Hohl et al. (2009) , each week had five training sessions, and one session per day, the training sessions was, week 1): 20 min at 15 m/min; week 2): 30 min at 20 m/min; week 3): 45 min at 22.5 m/min; week 4): 60 min, at 25 m/min.
Experimental diets
The experimental diets were isonitrogenous (approximately 17% protein, dry basis), isolipidic and isocaloric (approximately 360 kcal/100 g), formulated following the recommendations of the American Institute of Nutrition, AIN93 (for growing rats) diet (Reeves et al., 1993) . The two diets differed with respect to the nature of the protein source, casein or whey protein (Table 1) , the leucine added was at least 99.7% pure (Ajinomoto, São Paulo) and the amino acid compositions of the casein and whey protein used in the diets are shown in Table 2 . All the animals received the diets ad libitum.
Protein extraction and immunoblotting
The samples were prepared by homogenizing~100 mg of frozen tissue in Triton buffer (100 mM Tris, pH 7.4, 1% Triton X-100) containing 100 mM sodium pyrophosphate, 100 mM NaF, 10 mM EDTA, 10 mM Na 3 Vo 4 , 2 mM PMSF and 0.1 mg/ml aprotinin (Filiputti et al., 2008) . The total protein content of the diaphragm muscle was determined by the Lowry method (Lowry, Rosebrough, Farr, & Randall, 1951) . For immunoblotting, tissue homogenates were subjected to SDS-PAGE and transferred onto a nitrocellulose membrane, using a wide Biocom Western blot system (Bridge of Weir, UK). The blots were probed with the appropriate antibodies to determine the total mTOR (dilution 1:1000, ref#2972) and phosphor-mTOR (Ser 2448, dilution 1:1000, ref#2971S) using Cell Signaling Technology (Danvers, MA) and total p70S6K (dilution 1:1000, ref#sc-9379) and phosphor-p70S6K (Thr 389, dilution 1:1000, ref#sc-11759 ) using Santa Cruz (Santa Cruz, CA). Tubulin was the loading control (dilution 1:2000, ref#sc-8035), obtained from Santa Cruz (Santa Cruz, CA), and used to assess the level of the proteins in the diaphragm tissue. The appropriate secondary antibody conjugated to peroxidase and the BM chemiluminescence blotting system were used for detection. The bands were visualized by chemiluminescence (GE -ImageQuant LAS4000, Piscataway, NJ, USA) and the band intensities were quantified by processing with the program ImageJ (v. 1.44 for Windows).
Biochemical parameters
Kits for blood sampling. Six hours after the training session, blood samples were collected in Vacutainers, kept at 4°C, and then centrifuged at 3000 ×g (4°C, 12 min) to obtain the serum. The following determinations were carried out to assess the sera: uric acid, aspartate amino transferase (AST), alanine aminotransferase ALT, creatine kinase (CK) and lactate dehydrogenase (LDH). Standard enzymatic spectrophotometric determinations of glucose and cholesterol were also carried out employing Laborlab kits (São Paulo, Brazil).
AST
Principal of the method: Aspartate amino transferase (AST or GOT) catalyzes the transference of the amino group of aspartate to 2-oxyglutarate, obtaining oxaloacetate and glutamate. The catalytic concentration is determined by employing the coupled malto-dehydrogenase reaction (MDH), measuring the speed of disappearance of NADH at 340 nm (Scandinavian Society for Clinical Chemistry (SSCC), 1974).
The following interferents can cause: a) false high valuesacetaminophen, amphotericin b, alopurinol, oral contraceptives, methyldopa, phenothiazins, colchicine, narcotics, corticosteroids, barbiturates; and b) false low valuessalicylate (International Federation of Clinical Chemistry (IFCC), 1980).
ALT
Principal of the method: Alanine amino transferase (ALT or GPT) catalyzes the transference of the amino group of alanine to 2-oxy-glutarate, obtaining pyruvate and glutamate. The catalytic concentration is determined by employing the coupled lactate-dehydrogenase reaction (LDH), measuring the speed of disappearance of NADH at 340 nm (Scandinavian Society for Clinical Chemistry (SSCC), 1974).
The following interferents can cause: a) false high valuesantibiotics, meperidine, morphine, codeine and anti-hypertension agents; and b) false low valuesnone are known (International Federation of Clinical Chemistry (IFCC), 1980).
CK
Principal of the method: Creatine kinase (CK) catalyzes the phosphorization of ADP by creatine phosphate, obtaining creatine and ATP. The catalytic concentration is determined by employing the coupled reactions of hexokinase and glucose-6-phosphate dehydrogenase, measuring the speed of formation of NADPH at 340 nm (Scandinavian Society for Clinical Chemistry (SSCC), 1974).
The following interferents can cause: a) false high valuesamphotericin b, ampicillin, carbenicillin, chlorfibrate and chlorpromazine; and b) false low valuesnone are known (International Federation of Clinical Chemistry (IFCC), 1980).
Glucose
Principal of the method: The enzyme glucose oxidase catalyzes the oxidation of the glucose existing in the sample in the presence of oxygen, producing hydrogen peroxide. The enzyme peroxidase catalyzes the oxidation of the phenol by the hydrogen peroxide formed, in the presence of 4-amino-antipyrene, producing a reddish-pink compound (quinone imine), which shows maximum absorption at 500 nm, the intensity of the color being proportional to the glucose concentration in the sample (Trinder, 1969) .
The following interferents can cause: a) false high valuesascorbic acid above 5 mg/dL, hemoglobin above 0.2 g/dL and bilirubin above 40 mg/dL; and b) false low valuesnone are known (Henry, Cannon, & Winkelman, 1974) .
LDH
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The AIN93-G WP diet was made by substituting the whey protein for the casein of the AIN93 (standard) diet plus leucine (L) added.
the LDH activity in the sample (Scandinavian Society for Clinical Chemistry (SSCC), 1974).
The following interferents can cause: a) false high valuesmyocardial infarction, cardiac insufficiency, cancer, melanoma, acute leukemia, mononucleosis, pernicious anemia, sickle cell anemia, hemolytic anemia, cerebral hemorrhage, pulmonary infarction, liver diseases and muscular diseases; and b) false low valuesnone are known (International Federation of Clinical Chemistry (IFCC), 1980).
AU
Principal of the method: Uric acid in the sample suffers the action of uricase in the presence of oxygen, producing allantoin and hydrogen peroxide. The latter, in the presence of the phenolic reagent (TOOS) and 4-aminoantipyrene suffers the action of peroxidase producing a violet-colored complex (quinone imine) which shows maximum absorption at 500 nm (Trinder, 1969) .
The following interferents can cause: a) false high valuesascorbic acid above 20 mg/dL, acetozolamide, chlorotiazide, furosemide, methyldopa, phenothiazine and salicylates; and b) false low valuesacetohexamide, alopurinol, azathiopin, probenecid, mercaptopurine, coumarin, estrogens and sulfinpyrazone (Chu & Turkington, 1978) .
Creatinine
Principal of the method: Creatinine present in the sample reacts with picrate in an alkaline medium giving rise to a yellowy-red colored complex. The speed of formation of this complex is measured using 2-point kinetics during the initial reaction periods. The reaction of picrate with other chromogens present in the sample is slow, occurring in the final periods of the reaction, which does not interfere with the dosing of the creatinine (Cooper & Biggs, 1961) .
The following interferents can cause: a) false high valueshigh meat consumption, amphotericin B, cephazolin, cephalothin, chloranfenicol, dextran, furosemide, gentamicin, kanamicin, methicillin, vitamin C, barbiturates, lithium, mitramicin, methyldopa, triamterene and ketonic bodies; and b) false low valuesacetohexamide, alopurinol, azathiopin, probenecid, mercaptopurine, coumarin, estrogens and sulfinpyrazone (Martinek, 1970) .
Cholesterol
Principal of the method: The cholesterol esters present in the sample are hydrolyzed by the enzyme cholesterol esterase producing free cholesterol. The enzyme cholesterol oxidase, in the presence of oxygen, catalyzes the oxidation of the free cholesterol producing hydrogen peroxide. The enzyme peroxidase catalyzes the oxidation of the phenolic reagent (phenol) by the hydrogen peroxide formed, in the presence of 4-aminoantipyrene, producing a reddish-pink complex (quinone imine) which shows maximum absorption at 500 nm (Trinder, 1969) .
The following interferents can cause: a) false high valuessteroids, oral contraceptives, bromates, phenothiazin sulphonamides, phenitoin and aspirin; and b) false low valuessteroids, salicylates, canamycin, neomycin, tetracycline, estrogens, heparin, colchicine and anti-diabetic agents (Castelli & Levitas, 1977) .
Determination of plasma free amino acids
Serum free amino acids were extracted with methanol and derivatized with phenyl isothiocyanate (White, Hart, & Fry, 1986 ) and the PTH-derivatives chromatographed using a Luna C-18, 100 Ǻ; 5 μ, 250 ×4.6 mm (00G-4252-EQ) column, at 50°C. Quantification was done by comparison with a standard mixture and DL-2-aminobutyric acid was used as the internal standard (Sigma-Aldrich Corp, St Louis, MO, USA). The free amino acids were extracted in 80% ethanol and 0.1 M HCl, with 500 μL of 2-aminobutyric acid added as the internal standard. The mixture was sonicated for 10 min and further homogenized for 1 h, followed by centrifugation at 8,500 ×g for 15 min. The supernatant was filtered through a 0.22 mm membrane and a 40 μL aliquot derivatized as described above, subsequently injecting 20 μL into the liquid chromatograph. The retention times, in minutes, were: aspartate (ASP) 5.239, glutamate (GLU) 6.035, hydroxyproline (H-Pro) 9.467, asparagine (ASN) 10.884, glutamine (GLN) 11.441, serine (SER) 11.147, glycine (GLY) 11.709, threonine (THR) 13.693, histidine ( 
Proximate composition
The moisture, total ash, protein, and lipid contents were determined according to the Association of Official Analytical Chemists methods (AOAC, 2002) . The total carbohydrate content was inferred by difference.
Statistical analysis
The results were subjected to a statistical analysis using the software SPSS (Statistical Package for the Social Sciences), version 17.0. The data were tested for normality (Kolmogorov-Smirnov test) and homogeneity using the tools available therein. For parametric data, the multivariate analysis of variance (ANOVA) was used, and the means compared (Duncan test) adopting the value of p ≤ 0.05 as the criterion for statistical significance.
Results
Long-term supplementation showed no general trend of the diaphragm muscle mass with regard to dietary protein source. It will be noted, however, that while supplementation resulted in slightly significant (p > 0.05) lower body mass gains, the mass of the diaphragms was maintained mostly unaltered, but showing a minor increase when the level of addition was 4.5% (Table 3) .
The long-term supplementation of normal rats with leucine in this experiment produced a general increase in mTOR and p70S6K proteins in the diaphragm, both phosphorylated and unphosphorylated (Fig. 2) , the leucine supplementation at level of 6% was more effective in promoting a significant increase in mTOR levels in both forms.
The consequences of supplementation on the activities of AST, ALT, CK and LDH enzymes, plus the serum levels of glucose, uric acid, creatinine and cholesterol were determined in order to further assess the impact of long term supplemental leucine (Table 4 ). The complete amino acid profiles (Table 5 ) of sera detected no clear changes, with the exception of alanine and the branched chain amino acids. With regard to leucine, commensurate increases were observed at every level of supplementation, except that the sedentary maintained levels of leucine are 20% higher than the trained animals.
Discussion
No reports were found in the literature concerning the effects of whey protein or leucine on the diaphragm mTOR pathway, protein levels or muscle mass accretion. Considering the fact that this skeletal muscle exhibits several characteristics distinct from the rest of the skeletal muscles described above, it was remarkable to find that the dietary treatment, mainly leucine supplementation, resulted in increases in concentration of both the non-phosphorylated and phosphorylated biomarkers. Significant increases in mass of the diaphragm were observed as a result of training (p b 0.05), and increases were also observed due to supplementation with leucine, although these did not reach statistical significance (p = 0.08). On the other hand, other researchers observed increases in the protein content and muscle mass of the paw muscles, the gastrocnemius (Proud, 2007) .
The main mechanism by which leucine exerts its protein synthesis stimulating function, is by activating mTOR, a key protein in the process of cell proliferation (Proud, 2007) . Once activated, mTOR, in turn, activates the 4E-BP1 and p70S6K proteins, thus increasing the cell capacity to synthesize proteins (Kimball & Jefferson, 2004; Proud, 2004) . Besides the anabolic effect gained by activating mTOR, leucine also stimulates insulin secretion (da Silva et al., 2010; Filiputti et al., 2008) , thereby giving a further boost to anabolism. There is also evidence that supplementation with leucine for prolonged periods of time may have an anticatabolic effect on skeletal muscle (Sugawara, Ito, Nishizawa, & Nagasawa, 2007) . Fig. 2 shows that chronic supplementation with leucine (30 days) at the three levels tested (3, 4.5 and 6% of the total diet mass), with both protein sources ingested (casein and whey protein), was capable of increasing not only the activation of mTOR, as represented by the phosphorylated mTOR/total mTOR ratio ( Fig. 2A and B ), but also raise the absolute concentration of phosphorylated mTOR and total mTOR. These facts were also observed in the concentrations of the protein p70S6K. Although no studies on the diaphragm are available, intense studies, or others lasting 10 days, on the limb musculature (Proud, 2002) , reported the capacity of leucine to raise the phosphorylated mTOR/total mTOR ratio, but did not report any rise in the absolute concentrations of these proteins. Possibly the addition of leucine to the diet in the concentrations tested in a continuous way for 30 days, could have caused over use of the mTOR pathway and an upregulation of the concentrations of the proteins mTOR and p70S6K and their phosphorylated forms.
In both the sedentary and trained animals, the protein of the experimental diet (whey protein) caused a significant increase in the phosphorylated mTOR/total mTOR ratio when compared to the control group, which ingested casein, and this result was repeated for p70S6K. After 30 days of leucine supplementation, the sedentary animals that ingested casein (2A) showed a rise in the activation of the mTOR pathway at the 3 levels tested, although with no significant difference between the 3 levels. The same occurred with the group fed on WP but to a smaller extent. It is worth mentioning that WP contains about 33.2% more leucine than casein (Table 1) , and hence the level of leucine ingestion by the animals fed on WP was higher than that of the animals fed on casein, due to the different amino acid profiles of the two proteins. Thus the data could suggest that the levels used were sufficiently high to reach a 'plateau' of activation after Table 3 Mean (M) and standard error of the mean (SEM) of dietary intake and anthropometric parameters. 30 days of supplementation. In the trained animals fed on casein (2B), the response to the level varied when comparing the groups supplemented with 3 and 4.5% leucine, but with no significant difference between 4.5 and 6%, indicating that exercise increased the response of the mTOR pathway to supplementation with leucine at higher levels. On the other hand, in the animals fed on WP and trained, the effect of mTOR activation was repeated, with no significant difference between the three levels of supplementation with leucine. Thus the results suggested that supplementation with leucine resulted in increases in the anabolic proteins of the diaphragm of the Wistar rats.
Since mechanically ventilated patients are potentially vulnerable to ventilator-induced diaphragmatic dysfunctions (Vassilakopoulos, 2008) , such as diaphragmatic atrophy (Yang et al., 2002) , it is likely that proper stimulation of the anabolic pathways of the diaphragm could be useful in CMV-induced atrophy. Atrophy can develop rapidly, as early as 12 h after the initiation of CMV (McClung et al., 2007) , and is particularly pronounced in the diaphragm, where atrophies occur more frequently than in the peripheral skeletal muscles (Yang et al., 2002) . The response of mTOR and p70S6K (Fig. 2) was consistent with studies on other skeletal muscles (Chen, Sood, McIntire, Roth, & Rabkin, 2011; Li, Yin, Tan, Kong, & Wu, 2011; Zeanandin et al., 2011) . Although no studies on the diaphragm are available, the dose-dependent results obtained in the present study suggest that the different degrees of supplementation were well tolerated, and that the animals responded with increases in the concentration of anabolic proteins. Anthony et al. (2002) showed that the infusion of leucine resulted in the stimulation of protein synthesis in rats, even when maintaining the blood insulin concentration low by the concomitant infusion of somatostatin, thus signifying that the stimulatory effect of this amino acid on protein synthesis was independent of insulin (Anthony et al., 2002) . It was therefore, suggested that, although leucine can itself stimulate the release of insulin, it is likely that a substantial part of its anabolic effect may not proceed via the direct action of insulin.
No significant alterations in the liver (ALT and AST) and kidney (creatinine and uric acid) health parameters analyzed were observed with regard to chronic supplementation. In addition the muscle damage markers, CK and LDH, were not raised by any of the levels of leucine supplementation tested, a finding in agreement with those of other workers for peripheral skeletal muscles (Kirby et al., 2011; Stock et al., 2010) .
The results of the complete amino acid profiles (Table 5) were coherent with the results of Hambraeus, Bilmazes, Dippel, Scrimshaw, and Young (1976) , the concomitant decreasing trend observed in the concentrations of both valine and isoleucine as against the increases in leucine, being expected from their competitive absorption characteristics. Finally, considering that the concentrations of BCAA in the whey proteins, including leucine, are higher than in casein, it was reasonable to encounter higher levels of the anabolic proteins when the dietary protein was WP, as seen in most of the profiles shown in Fig. 2 . The plasma alanine levels were also shown to increase in a dose-dependent way with leucine supplementation. Possibly the glucose-alanine cycle carried out mainly in the skeletal muscles, which consumes branched-chain amino acids and glucose producing alanine, was more active in the animals supplemented with leucine, which is a substrate for this cycle and hence for the production of alanine (Felig, 1973) .
In general, leucine supplementation of both casein and the leucinerich whey protein had some impact on the body mass gain of the animals, resulting in a greater mass accretion in the sedentary animals as compared to their trained cohorts, and reaching a maximum at the 4.5% level for both groups. This effect was reversed when the leucine addition reached 6%, in agreement with an associated reduction in food intake (Table 1) , and the observation made by Laviano, Meguid, Inui, and Rossi-Fanelli (2006) and Blouet et al.(2009) that leucine may inhibit food intake. Taken together, these data suggest that the chronic leucine supplementation of normal Wistar rats stimulates the protein anabolic pathways in the diaphragm. However, up to the present, it is not possible to know if the increase in these biomarker proteins resulted in a net mass gain for the diaphragm or not, especially considering that the combination of training and leucine supplementation at the level of 6% did, when relating the mass of the diaphragm to the body mass of the animal. Considering the fact that supplemental leucine was translated into greater levels of mTOR and p70S6K, both in the phosphorylated and non-phosphorylated forms, although not resulting in a statistically significant difference (p = 0.08), the accretion of muscle protein or diaphragm mass is an intriguing issue that should merit investigation.
Since atrophy of the diaphragm can develop as early as 2 h after the initiation of CMV (McClung et al., 2007) , mechanically ventilated patients are highly vulnerable to ventilator-induced diaphragmatic dysfunction (Welvaart et al., 2011) . In the event that these anabolic proteins do fulfill their mass accretion purpose when the diaphragm muscle is facing a loss of mass, it would be of interest to know if proper stimulation of the diaphragm's anabolic pathways with leucine could be useful in the prevention of CMV-induced atrophy.
Limitation of this study
As a limitation of this study: a) the experimental design testing casein and whey protein did not allow one to know whether the milk proteins could themselves generate the relevant amino acids needed to promote the increase in diaphragm mass, and no difference was observed as compared to the other proteins. Possibly a control without casein or whey protein could confirm this effect; and b) in some cases the observed increase in weight of the diaphragm was only 0.10 g, and there was no significant increase in diaphragm mass. The mass of the rat diaphragm is small, about 50 mg, and therefore weighing may not be the best way of evaluating the anabolic effect of this muscle. Histological studies could maybe reveal any significant differences between the effects of the different supplementations, and were not carried out in this study.
Conclusions
It was concluded that the combination of milk proteins (whey protein and casein), leucine and exercise was able to activate the mTOR pathway of the diaphragm, maximal activation being obtained when the level of leucine addition was 4.5% or 6%. The different protein sources, whey protein and casein, stimulated the anabolic mTOR pathway with similar intensity, while exercise increased the activation. The highest doses of supplemental leucine elicited lower food intakes and lower body mass gains, followed by some alterations in the plasma concentrations of BCAAs as compared to the controls, in agreement with results previously reported by other authors. The liver (AST and ALT) and kidney (uric acid and creatinine) health biomarkers were not significantly altered, and nor were the muscle damage indicators (CK and LDH). The combination of exercise, leucine and milk proteins (whey protein or casein) may be a viable alternative to maximize activation of the mTOR pathway and provide amino acids for protein synthesis in the diaphragm. ASP: aspartate, ASN: asparagine, GLU: glutamate, GLN: glutamine, SER: serine, GLY: glycine, THR: threonine, HIS: histidine, ALA: alanine, ARG: arginine, TYR: tyrosine, VAL: valine, MET: methionine, ILE: isoleucine, PHE: phenylalanine, TRP: tryptophan, LEU: leucine, LYS: lysine, CYS: cysteine, PRO: proline, H-Pro: hydroxyproline. The branched chain amino acids are in bold. The AIN93-G WP diet was made by substituting the whey protein for the casein of the AIN93 (standard) diet plus leucine (L) added. Different letters indicate significant differences between groups, ANOVA was used and means were compared (Duncan test), adopting the value of p b 0.05 as a criterion for statistical significance.
